Yubo International Biotech Ltd
Close on Oct 16, 2026
- Market cap
- $886.19K
- P/E (TTM)
- –
- Dividend yield
- –
About Yubo International Biotech
Electromedical & Electrotherapeutic Apparatus, SIC 3845
The company is a biotechnology enterprise that focuses on the research, development, and commercial application of endometrial stem cells. Through its Chinese operating affiliate, it markets various consumer goods under the VIVCELL brand name, including skincare, hair care, respiratory healthcare products, healthy beverages, and personal care items for men and women. In addition to physical goods, the business provides specialized stem cell solutions such as cell testing and health management consulting. Its customer base consists of individual consumers who purchase its personal healthcare items and clients who utilize its diagnostic and wellness advisory services.
The enterprise conducts its day-to-day operations in the People's Republic of China, maintaining operational and administrative entities in locations including Beijing, Chengdu, Shenzhen, and Hong Kong. The organization is structured as a United States holding company that directs its Chinese business activities through contractual arrangements with domestic entities rather than direct equity ownership. All executive officers and directors are based in China, where substantially all corporate activities and operational assets are situated.
Summary of the business section of Yubo International Biotech's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Yubo International Biotech Ltd
- Headquarters
- Beijing, F4
- Address
- Room 105, Building 5, 31 Xishiku Avenue 00000
- Phone
- 86 (010) 6615-5141
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- New York
- Fiscal year ends
- December 31
- Auditor
- HCL PLLC, Chicago, IL
Stock & identifiers
- Ticker
- YBGJ
- Exchange
- OTC
- IPO date
- Aug 24, 2021
- Shares outstanding
- 170M, Aug 11, 2026
- Public float
- $1, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 895464
- CUSIP
- 988366100
- ISIN
- US9883661004
- EIN
- 11-3074326
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yang Wang | Chief Executive Officer, Director | 25,811,400 |
| Jun Wang | President, Director | 81,943,800 |
| Nanping Hu | Director | 0 |
Corporate history
Events identified from SEC filings